-
Mashup Score: 1E-selectin Inhibitor Uproleselan May Bolster SOC Efficacy in AML - 13 day(s) ago
Richard M. Stone, MD, highlights how uproleselan disrupts E-selectin in the AML tumor microenvironment, the variety of AML regimens that uproleselan may amplify in efficacy, including chemotherapies and venetoclax combinations, and the need for further research to determine whether minimal residual disease negativity rates will improve patient prognoses.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Mazyar Shadman, MD, MPH, presents data from a matching adjusted indirect comparison (MAIC) of the efficacy of zanubrutinib versus acalabrutinib in relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) based on data from the Phase 3 ALPINE and Phase 3 ASCEND trials.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Outcomes After Stem Cell Transplant in Elderly Patients With Acute Myeloid Leukemia Have Improved Since 2000 - 1 month(s) ago
Outcomes After Stem Cell Transplant in Elderly Patients With Acute Myeloid Leukemia Have Improved Since 2000
Source: www.aacr.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 12Ohio State leukemia researcher honors her mentor’s legacy - 1 month(s) ago
Twists of fate led Ann-Kathrin Eisfeld, MD, to train under two legends in cancer research. Today, she takes the lessons of her mentors to heart as she directs the Clara D. Bloomfield Center for Leukemia Outcomes Research @OSUCCC_James.
Source: health.osu.eduCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Discombobulation Caused By Cancer - 1 month(s) ago
I recently heard a story about a patient’s personality change because of cancer, and it reminded me of the hyperactive delirium I experienced.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0First Patient With AML Dosed With Novel Ziftomenib Plus Xospata - 1 month(s) ago
A patient received a dose of the novel menin inhibitor, ziftomenib, plus Xospata in a phase 1 trial for patients with AML.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 4Remission from B-Cell ALL with Chemo-Free Induction Therapy - 2 month(s) ago
Tyrosine kinase inhibitors (TKI) targeting BCR-ABL are an integral component of initial therapy for Philadelphia chromosome-positive acute
Source: www.jwatch.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Remembering My Days as a Patient With Leukemia - 2 month(s) ago
“Waiting” described the waiting room at Children’s Hospital to get my chemotherapy. “My Days” was a remembrance of the year I was diagnosed with leukemia.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 12Ohio State leukemia researcher honors her mentor’s legacy - 2 month(s) ago
Twists of fate led Ann-Kathrin Eisfeld, MD, to train under two legends in cancer research. Today, she takes the lessons of her mentors to heart as she directs the Clara D. Bloomfield Center for Leukemia Outcomes Research @OSUCCC_James.
Source: health.osu.eduCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Acute Lymphocytic Leukemia - Cancer Stat Facts - 2 month(s) ago
Acute Lymphocytic Leukemia statistics
Source: seer.cancer.govCategories: General Medicine News, Onc News and JournalsTweet
Learn more about the potential utility of uproleselan in R/R acute myeloid #leukemia (AML) from Dr Richard M. Stone, MD, of @DanaFarber, here: https://t.co/iFgV79nS56